Spaceflight is outpacing the medicine built to support it.
The Opportunity
The current healthcare systems built for the astronaut corps were never designed for today’s mission volume and commercial scale. They do not support the new diversity of crew health and medical conditions. The care provided by legacy government programs and private consultants is fragmented. And none of them share common standards. OrbitalMed exists to close that gap of on-orbit medicine and training.
Expanding Frontier
NASA Artemis is preparing for lunar return. Four commercial station operators are competing to succeed the ISS. Suborbital tourism is operational. Microgravity manufacturing is moving to commercial pilots.
Fragmented & underserved
No unified model links prevention, intervention, and recovery. Standards are misaligned. That drives operational risk. It raises insurance cost. It adds regulatory uncertainty.
Earth + orbit
In orbit, the margin for error is zero. What works there becomes a more resilient option on Earth. It strengthens care in remote and resource-limited settings.
The market is large, growing, and structurally underserved.
The window to establish the integrated standard is open now.
(1) McKinsey & Company / World Economic Forum — Global Space Economy forecast ($1.8T by 2035). mckinsey.com
(2) Coherent Market Insights — Global Space Medical Service Market Report ($3.2B by 2032, 12.5% CAGR). coherentmarketinsights.com
(3) Northern Sky Research (Analysys Mason) — Space Tourism & Suborbital Market Analysis. nsr.com
(4) NASA Office of Inspector General — ISS Transition Plan & Commercial LEO Destinations. oig.nasa.gov
A $1.8 trillion space economy is expanding
faster than the medicine that supports it.
$0.0T
Key Market Drivers
- NASA Artemis program: crewed lunar missions returning by late 2020s 4
- Anticipated 20 crew launches and 70 commercial launches per year
- 4+ commercial space stations in development (Axiom, Vast, Orbital Reef, Starlab) 4
- Suborbital tourism operational; 100+ private citizens flown to date 3
- ISS deorbit by 2030 creates transition demand for commercial providers 4
market by 20322
0.0%
(McKinsey/WEF) 1
$0.0B
medical services2